Advanced BioDesign as an immunotechnology specialist, provides a tailored and high value solution.
Advanced BioDesign has raised €9.0M across 1 funding round from 1 investor, most recently a round in Feb 2020. Based in Saint Priest, France; founded 2010; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-02-25 | Other | €9.0M |
| Xerys |
| View deal → |
